Home > Healthcare > Biotechnology > Biotechnology R&D > Hematopoietic Stem Cell Transplantation Market

Hematopoietic Stem Cell Transplantation Market Size

  • Report ID: GMI6276
  • Published Date: Jul 2023
  • Report Format: PDF

Hematopoietic Stem Cell Transplantation Market Size

Hematopoietic Stem Cell Transplantation Market size was valued to be USD 2.6 billion in 2022 and is expected to reach USD 6.2 billion in 2032 with a CAGR of 9.3% by 2032 due to the increasing incidence of leukemia, rising success rate of transplantation, and technological advancements in the transplantation procedures.

 

Hematopoietic stem cells (HSCs) are multipotent precursors that have self-renewal capacity and the ability to regenerate all the different cell types that comprise the blood-forming system. Hematopoietic stem cell transplantation (HSCT) includes the intravenous infusion of hematopoietic stem cells to reestablish blood cell production in patients whose immune system or bone marrow are damaged. This technique is used to treat numerous malignant and non-malignant diseases such as leukemia, lymphoma, sickle cell disease, and congenital neutropenia.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global market size for hematopoietic stem cell transplantation was valued to be USD 2.6 billion in 2022 and is expected to record a CAGR of 9.3% by 2032, owing to the increasing incidence of leukemia, rising success rate of transplantation, and technological advancements.

The autologous transplant therapy segment held the largest market share of 57.6% in 2022 as it reduces the time and resources required for donor search and facilitates a quicker transplantation process.

North America market is expected to reach USD 2.2 billion by 2032 because the region boasts a well-developed and advanced healthcare infrastructure, including specialized transplant centers and comprehensive cancer centers.

Pluristem Therapeutics Inc., Sanofi, Taiga Biotechnologies, Inc., CellGenix GmbH, Novartis AG, Regen Biopharma Inc., Kiadis Pharma, Marker Therapeutics, Inc., Escape Therapeutics, Inc., GlaxoSmithKline plc, Merck KGaA, Bluebird Bio, Inc., and Talaris Therapeutics.

Hematopoietic Stem Cell Transplantation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 439
  • Countries covered: 20
  • Pages: 254
 Download Free Sample